Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers.

a technology of lysyl oxidase and activity, which is applied in the direction of enzymology, plant/algae/fungi/lichens ingredients, drug compositions, etc., can solve the problems of inability to provide criteria, inability to obtain objective criteria enabling the effect of actives, and inability to form the network of elastic fibers correctly. , to achieve the effect of stimulating the elasticity of tissues, reducing skin wrinkles, and reducing skin wrinkl

Inactive Publication Date: 2010-02-18
BASF BEAUTY CARE SOLUTIONS FRANCE SAS
View PDF6 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes a method for stimulating the formation of elastic fibers in tissues, which can be used to improve skin appearance and reduce wrinkles. The method involves using a specific form of the enzyme lysyl oxidase, called LOXL, and its promoter. The invention also includes a cosmetic, neutraceutical, and pharmaceutical composition that contains an active substance to stimulate the expression of LOXL. The active substance can be a specific region of the LOXL gene or a compound that promotes the activity of LOXL. Overall, the invention provides a way to induce neo-elastogenesis and improve the quality of skin tissue.

Problems solved by technology

Similarly, in scars, the network of elastic fibers does not form correctly.
The prior art does not enable providing criteria which enable evaluating the impact of an active principle in dermato-cosmetology on a functional neo-elastogenesis.
It is also very difficult to obtain objective criteria enabling the Impact of these actives to be judged.
Furthermore, at the present time, animal experimentation is forbidden in cosmetics in Europe and human experimentation is ethically disputed.
It is therefore unacceptable to the inventors to carry out a screening method, for cosmetic applications, which makes use of animals or human beings.
However, those studies did not enable developing a method of identifying active principles which enable stimulating the formation of functional elastic fibers.
The prior art does not therefore enable providing active principles which enable stimulating the formation of functional elastic fibers.
Furthermore, the prior art does not enable a dynamic tracking of the zone of expression of the Isoform of the lysyl oxidase LOXL, notably due to the fact that the methods provided by the prior art are imprecise.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers.
  • Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers.
  • Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers.

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0130]The invention has first of all covered the development of novel specific antibodies of LOX and LOXL but which are capable of detecting their mature forms. The antibodies were developed against the mature regions of LOX and LOXL. The antigenic regions were selected in order to present the minimum of similarity with the corresponding regions on the other isoforms of the lysyl oxidases (LOs). The antibodies obtained against the regions of the peptides LOXV228-S280 (were called anti-LOXmat and similarly for the antibodies obtained against the region of the peptides LOXLR231-G368 called anti-LOXLpro.

[0131]In FIG. 1: description of the sequences of the LO defined for giving the specific antibodies: This figure represents the steps which have led to the selection of the antigenic regions in order to develop the anti-LOX and anti-LOXL antibodies.

[0132]FIG. 1(A): Schematic representation of hLOX (human LOX protein) and hLOXL (human LOXL protein).

[0133]The sequences of hLOX and hLOXL ar...

example 2

Immuno-detection of LOX and LOXL of Muscle Cells by Virtue of the Novel Antibodies Anti LOX and Anti-LOXL

On FIG. 2:

[0145]FIG. 2 represents photographs of electrophoreses which were carried out as indicated below. These electrophoreses demonstrate the characterization of the mature proteins of LOX and LOXL, of smooth muscle cells (SMC) by virtue of the antibodies anti-LOX and anti-LOXL, Identified In Example 1.

[0146]The proteins of the cell strain (L) and of the cell culture medium (M) of a cell line of rat smooth muscle (developed by Jean-Marie Daniel Lamaziere, Bordeaux) were extracted and detected by western blotting by using the antibodies anti-LOXLmat, anti-LOXmat, anti-LOXLpro and anti-LOXpro. The cells were cultivated at 37° C. in an atmosphere of 5% CO2 in DMEM medium (Sigma) containing 10% foetal calf serum, 2 mM glutamine and 50 μg / ml gentamycin.

[0147]The cell strain proteins, which are washed twice with PBS buffer, were extracted for 2 hours at 4° C. with slow agitation in...

example 3

Demonstration of the Role of LOX and LOXL in Elastocienesis

[0151]The inventors have demonstrated that the LOX and LOXL proteins can be associated with the formation of connective tissue in the dermis of reconstructed skin models by Immuno-histochemistry (FIG. 3). This demonstration was obtained without any ambiguity by virtue of the use of anti-LOX and anti-LOXL antibody couples, directed against the pro-enzymatic regions and mature regions of the two enzymes (LOX and LOXL).

[0152]On FIG. 3 representation is made of the immuno-histological detection of LOXL and LOX in the reconstructed skin (RS) and normal human skin.

[0153]The Immuno-detection of LOXL (A, C, E, G) on the reconstructed skin at days 16 (A), 35 (C), and 45 (E), by using anti-LOXLR231-G368 (A, C, E) or anti-LOXLR231-G368 adsorbed with the corresponding peptide GST-LOXLR21-G368 before the immuno-detection (G). The immuno-detection of LOX (B, D, F, H) at days 16 (B), 35 (D), and 45 (F), by using anti-LOXV228-S279 (B, D, F)...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
v/vaaaaaaaaaa
molecular massaaaaaaaaaa
molecular massaaaaaaaaaa
Login to View More

Abstract

The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform.The Invention relates notably to a method of identifying an active principle which stimulates the formation of elastic fibers.The aim of the invention is mainly to provide such a method of identification so as to provide compositions which enable stimulating the formation of elastic fibers.

Description

[0001]The invention relates to the stimulation of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform.STATE OF THE ART[0002]The properties of resistance and of elasticity of the skin and of the mucous membranes are essentially defined by the collagen fibers and elastin fibers of the dermis. Elastin is a protein which makes up the elastic fibers by combining itself with other molecules such as fibrillins and MAGPs (Microflbrillar Associated Glycoproteins).The elastic fibers are formed of elastin deposited on the microfibrils. Elastin is synthesized in the form of soluble tropoelastin which acquires its physico-chemical properties (insolubility, elasticity) after the intra- and inter-molecular cross-linking of it by a lysyl oxidase, and its deposit on the microfibrils. The elastic fibers are responsible for the elastic property of the organs which contain them (vessels, pulmonary parenchyma, elastic cartilages, skin . . . ). The ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K36/00A61K36/23A61K36/906A61K36/54A61K36/899A61K36/81A61K38/00A61K31/22A61P17/00A23L1/30A61K8/66A61K31/23A61K35/74A61K36/185A61K36/31A61K36/896A61K36/9064A61K38/43A61K38/44A61Q19/00A61Q19/08C12N9/06C12Q1/26C12Q1/68G01N33/68
CPCA61K8/66C12Y104/03013A61K36/185A61K36/23A61K36/31A61K36/54A61K36/81A61K36/896A61K36/899A61K36/9064A61Q19/00A61Q19/08C12N9/0022G01N2500/04A61K35/74A61K38/00A61K2300/00A61K38/44A61P17/00A61P17/02A61K8/97
Inventor PERRIER, ERICCENIZO, VALERIEBOUEZ, CHARBELSOMMER, PASCALDAMOUR, ODILEGLEYZAL, CLAUDINEANDRE, VALERIEREYMERMIER, CORINNE
Owner BASF BEAUTY CARE SOLUTIONS FRANCE SAS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com